SILICON VALLEY, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) — Predicine, Inc., a global molecular insights company, announced today that it will present four posters at the ESMO conference being held September 9-13, 2022, in Paris, France. Predicine’s liquid biopsy portfolio includes high performing assays that provide translational insights to aid in potential cancer therapeutic strategies....
Predicine to Introduce PredicineALERT MRD Assay and Present 12 Posters at AACR 2023 Conference